scholarly article | Q13442814 |
P50 | author | Maximilien Barret | Q53082360 |
P2093 | author name string | Frédéric Prat | |
P2860 | cites work | T1 squamous cell carcinoma of the esophagus: long-term outcomes and prognostic factors after esophagectomy | Q86738502 |
Non-surgical versus surgical treatment for oesophageal cancer | Q24186005 | ||
Magnification endoscopy in esophageal squamous cell carcinoma: a review of the intrapapillary capillary loop classification | Q27010212 | ||
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 | Q27861047 | ||
Radiofrequency ablation in Barrett's esophagus with dysplasia | Q28246453 | ||
Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett's oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial | Q28302503 | ||
Endoscopic submucosal dissection for Barrett's early neoplasia: a multicenter study in the United States | Q30275818 | ||
Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: acute-phase and intermediate results of a new treatment approach | Q30716481 | ||
A risk model for esophagectomy using data of 5354 patients included in a Japanese nationwide web-based database | Q30803353 | ||
A comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data | Q31156910 | ||
Meta-analysis of endoscopic submucosal dissection versus endoscopic mucosal resection for tumors of the gastrointestinal tract | Q33495237 | ||
Oesophageal carcinoma | Q34325751 | ||
Global incidence of oesophageal cancer by histological subtype in 2012. | Q34443765 | ||
Evaluation of a minimally invasive cell sampling device coupled with assessment of trefoil factor 3 expression for diagnosing Barrett's esophagus: a multi-center case-control study | Q35027021 | ||
Prediction of response to endoscopic therapy of Barrett's dysplasia by using genetic biomarkers. | Q35031044 | ||
The effectiveness of endoscopic submucosal dissection followed by chemoradiotherapy for superficial esophageal cancer. | Q35048093 | ||
Thirty-day mortality underestimates the risk of early death after major resections for thoracic malignancies. | Q35540262 | ||
Clinical Efficacy of Endoscopic Submucosal Dissection for Adenocarcinomas of the Esophagogastric Junction | Q35579540 | ||
Endoscopic ultrasound-guided fine-needle aspiration biopsy in esophageal cancer | Q36095838 | ||
Identification of volumetric laser endomicroscopy features predictive for early neoplasia in Barrett's esophagus using high-quality histological correlation | Q36141712 | ||
Update on the paris classification of superficial neoplastic lesions in the digestive tract | Q36149733 | ||
Narrow band imaging versus lugol chromoendoscopy to diagnose squamous cell carcinoma of the esophagus: a systematic review and meta-analysis | Q36249315 | ||
Prognostic factors for salvage endoscopic resection for esophageal squamous cell carcinoma after chemoradiotherapy or radiotherapy alone. | Q37184149 | ||
Dynamic clonal equilibrium and predetermined cancer risk in Barrett's oesophagus | Q37191910 | ||
Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett's esophagus | Q37274429 | ||
Narrow band imaging for characterization of high grade dysplasia and specialized intestinal metaplasia in Barrett's esophagus: a meta-analysis | Q37702125 | ||
Endoscopic resection and ablation versus esophagectomy for high-grade dysplasia and intramucosal adenocarcinoma | Q37807588 | ||
Detection of lymph node metastases in esophageal cancer. | Q37866765 | ||
Diagnostic accuracy of EUS in differentiating mucosal versus submucosal invasion of superficial esophageal cancers: a systematic review and meta-analysis | Q37960669 | ||
Systematic review with meta-analysis: race-specific effects of alcohol and tobacco on the risk of oesophageal squamous cell carcinoma. | Q38147572 | ||
The clinical consequences of advanced imaging techniques in Barrett's esophagus | Q38177553 | ||
Efficacy and safety of endoscopic submucosal dissection for superficial squamous esophageal neoplasia: a meta-analysis | Q38195211 | ||
Fluorescence imaging for the detection of early neoplasia in Barrett's esophagus: old looks or new vision? | Q38217925 | ||
Comparison of EMR and endoscopic submucosal dissection for en bloc resection of early esophageal cancers in Japan | Q57902503 | ||
The Development and Validation of an Endoscopic Grading System for Barrett’s Esophagus: The Prague C & M Criteria | Q58104636 | ||
Endoscopic esophageal mucosal resection using a transparent tube | Q68684817 | ||
Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease | Q73169047 | ||
Successful en-bloc resection of large superficial tumors in the stomach and colon using sodium hyaluronate and small-caliber-tip transparent hood | Q73829142 | ||
Esophageal stenosis after endoscopic mucosal resection of superficial esophageal lesions | Q78853372 | ||
The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002 | Q79339743 | ||
High-resolution endoscopy plus chromoendoscopy or narrow-band imaging in Barrett's esophagus: a prospective randomized crossover study | Q81273794 | ||
The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence | Q81290009 | ||
Predictive factors of coexisting cancer in Barrett's high-grade dysplasia | Q82376129 | ||
Do we still need EUS in the workup of patients with early esophageal neoplasia? A retrospective analysis of 131 cases | Q83312360 | ||
Safety and efficacy of multiband mucosectomy in 1060 resections in Barrett's esophagus | Q83509671 | ||
Predictors of postoperative stricture after esophageal endoscopic submucosal dissection for superficial squamous cell neoplasms | Q84143478 | ||
Endoscopic submucosal dissection plus radiofrequency ablation of neoplastic Barrett's esophagus | Q84962406 | ||
Outcomes of endoscopic submucosal dissection versus endoscopic mucosal resection in management of superficial squamous esophageal neoplasms outside Japan | Q85035832 | ||
Efficacy and safety of Hybrid-APC for the ablation of Barrett's esophagus | Q85447257 | ||
Thoracolaparoscopic dissection of esophageal lymph nodes without esophagectomy is feasible in human cadavers and safe in a porcine survival study | Q85681871 | ||
Clinical outcome in patients treated with endoscopic submucosal dissection for superficial Barrett's neoplasia | Q86028611 | ||
Remission of Barrett's esophagus with early neoplasia 5 years after radiofrequency ablation with endoscopic resection: a Netherlands cohort study | Q86510342 | ||
Multimodality endoscopic eradication for neoplastic Barrett oesophagus: results of an European multicentre study (EURO-II). | Q38366775 | ||
Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial | Q38433659 | ||
Systematic review: the prevention of oesophageal stricture after endoscopic resection. | Q38485909 | ||
Continuing rapid increase in esophageal adenocarcinoma in England and Wales | Q39171596 | ||
Endoscopic submucosal dissection for early Barrett's neoplasia | Q39384186 | ||
Results of radiation therapy for superficial esophageal cancer using the standard radiotherapy method recommended by the Japanese Society of Therapeutic Radiology and Oncology (JASTRO) Study Group. | Q40333664 | ||
ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus | Q40365358 | ||
A randomized trial comparing multiband mucosectomy and cap-assisted endoscopic resection for endoscopic piecemeal resection of early squamous neoplasia of the esophagus | Q41143486 | ||
A randomised trial of endoscopic submucosal dissection versus endoscopic mucosal resection for early Barrett's neoplasia | Q41151377 | ||
Early esophageal cancer in Europe: endoscopic treatment by endoscopic submucosal dissection. | Q41723130 | ||
Acetic acid spray is an effective tool for the endoscopic detection of neoplasia in patients with Barrett's esophagus | Q42987084 | ||
Endoscopic submucosal dissection is superior to conventional endoscopic resection as a curative treatment for early squamous cell carcinoma of the esophagus (with video). | Q43028966 | ||
Combination of endoscopic submucosal dissection and chemoradiation therapy for superficial esophageal squamous cell carcinoma with submucosal invasion | Q43078160 | ||
Is it justified to ablate flat-type esophageal squamous cancer? An analysis of endoscopic submucosal dissection specimens of lesions meeting the selection criteria of radiofrequency studies. | Q43572590 | ||
Longer inspection time is associated with increased detection of high-grade dysplasia and esophageal adenocarcinoma in Barrett's esophagus | Q43785152 | ||
Ablation of residual Barrett's epithelium after endoscopic resection: a randomized long-term follow-up study of argon plasma coagulation vs. surveillance (APE study). | Q43859918 | ||
External beam radiation therapy followed by high-dose-rate brachytherapy for inoperable superficial esophageal carcinoma | Q43909987 | ||
Comparison of the clinicopathological characteristics and results of endoscopic submucosal dissection for esophagogastric junction and non-junctional cancers | Q43929910 | ||
Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus | Q44224457 | ||
EMR combined with chemoradiotherapy: a novel treatment for superficial esophageal squamous-cell carcinoma | Q44743769 | ||
A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group Study (JCOG9708). | Q45956336 | ||
Diagnostic yield of methylene blue chromoendoscopy for detecting specialized intestinal metaplasia and dysplasia in Barrett's esophagus: a meta-analysis | Q46667000 | ||
Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett's esophagus at two high-volume centers | Q46723942 | ||
Chromoendoscopy and narrow-band imaging compared with high-resolution magnification endoscopy in Barrett's esophagus | Q46777125 | ||
Endoscopic submucosal dissection in patients with early esophageal squamous cell carcinoma: results from a prospective Western series | Q46973588 | ||
Use of immunohistochemical biomarkers as independent predictor of neoplastic progression in Barrett's oesophagus surveillance: A systematic review and meta-analysis. | Q47104584 | ||
Nitrous oxide cryotherapy for treatment of esophageal squamous cell neoplasia: initial multicenter international experience with a novel portable cryoballoon ablation system (with video). | Q47909987 | ||
Development and Validation of a Classification System to Identify High-Grade Dysplasia and Esophageal Adenocarcinoma in Barrett's Esophagus Using Narrow-Band Imaging | Q48069378 | ||
Improved diagnostic stratification of digitised Barrett's oesophagus biopsies by TP53 immunohistochemical staining. | Q48508273 | ||
Endoscopic radiofrequency ablation for early esophageal squamous cell neoplasia: report of safety and effectiveness from a large prospective trial | Q49443092 | ||
Complex early Barrett's neoplasia at 3 Western centers: European Barrett's Endoscopic Submucosal Dissection Trial (E-BEST). | Q50457547 | ||
Clinical outcomes of endoscopic submucosal dissection for superficial Barrett's adenocarcinoma. | Q50478643 | ||
Single center experience of endoscopic submucosal dissection (ESD) in early Barrett's adenocarcinoma. | Q50630067 | ||
Use of modified multiband ligator facilitates circumferential EMR in Barrett's esophagus (with video). | Q51213403 | ||
Endoscopic management of Barrett's esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. | Q51330146 | ||
Advantages of endoscopic submucosal dissection versus endoscopic oblique aspiration mucosectomy for superficial esophageal tumors. | Q51731287 | ||
Risk of perforation during dilation for esophageal strictures after endoscopic resection in patients with early squamous cell carcinoma. | Q51733001 | ||
Prospective evaluation of the macroscopic types and location of early Barrett's neoplasia in 380 lesions. | Q53024547 | ||
Randomized trial on endoscopic resection-cap versus multiband mucosectomy for piecemeal endoscopic resection of early Barrett's neoplasia. | Q53085950 | ||
Results of chemoradiotherapy for stage I esophageal cancer in medically inoperable patients compared with results in operable patients. | Q53124846 | ||
Lymphatic tumor emboli detected by D2-40 immunostaining can more accurately predict lymph-node metastasis. | Q53241194 | ||
The impact of endoscopic ultrasound and computed tomography on the TNM staging of early cancer in Barrett's esophagus. | Q53517367 | ||
Efficacy of the CryoBalloon Focal Ablation System for the eradication of dysplastic Barrett's esophagus islands. | Q54782548 | ||
Aberrant p53 protein expression is associated with an increased risk of neoplastic progression in patients with Barrett's oesophagus | Q57259733 | ||
Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline | Q57752476 | ||
Long-Term Outcome and Metastatic Risk After Endoscopic Resection of Superficial Esophageal Squamous Cell Carcinoma | Q57902278 | ||
P433 | issue | 3 | |
P304 | page(s) | 256-265 | |
P577 | publication date | 2018-03-15 | |
P1433 | published in | Annals of Gastroenterology | Q15758811 |
P1476 | title | Diagnosis and treatment of superficial esophageal cancer | |
P478 | volume | 31 |
Q99565375 | Modeling the Cost-effectiveness of Esophageal Cancer Screening in China |
Q90049366 | Relationship of lymphovascular invasion with lymph node metastasis and prognosis in superficial esophageal carcinoma: systematic review and meta-analysis |
Q64248614 | Resection of Mucosal and Submucosal Gastrointestinal Lesions and a Double Endoscope Experience |
Q89770918 | The possibility of endoscopic treatment of cN0 submucosal esophageal cancer: results from a surgical cohort |
Q64101703 | WISP2 exhibits its potential antitumor activity via targeting ERK and E-cadherin pathways in esophageal cancer cells |
Search more.